Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Regis Healthcare Limited (REG.AX)
Armadale, VIC, AU
Regis Healthcare Limited is a leading Australian provider specializing in comprehensive care services for the elderly. The company operates a network of residential aged care facilities and delivers a broad spectrum of in-home support. These home-based offerings include personal assistance such as hygiene and mobility, rehabilitation, and practical aid with household tasks like cleaning, cooking, and shopping, along with transportation and social outings. Regis also offers companionship and manages both government-funded and private home care programs. Additionally, the company owns and operates specialized retirement and independent living villages, providing residents with services including laundry, meals, cleaning, and access to allied health professionals for physiotherapy, podiatry, diversional therapy, and other therapeutic programs. Its aged care portfolio covers long-term 'ageing-in-place' solutions, short-term respite breaks, specialized dementia care, and dignified palliative care. The company further extends its services to in-home disability support and veterans' home care, offers therapeutic interventions for community members, retirement village residents, and those in low care homes, and manages Day Respite centres. As of mid-2022, Regis Healthcare Limited managed 64 residential aged care homes. Established in 1994, the company was formerly named Fairway Investment Holdings Pty Ltd before adopting its current name in 2014, and its main office is located in Armadale, Australia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.39% | +7.52% | -0.75% | -5.32% | -16.81% | -5.32% | -18.67% | +193.75% | +230.65% | +34.01% | +63.68% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | +1 |
| Buy | 3 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+13.7% ★ Q4'25: +39.3% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%+325.0% ★ Q4'25: +210.2% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+27.8% Q4'25: +28.7% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%+16.5% ★ Q4'25: +3.0% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%— Q4'25: -21.5% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%+0.9% Q4'25: +0.6% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×0.02× ★ Q4'25: 0.04× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 6 Rev. Ana. 5 EPS Ana. |
Jun 2027 6 Rev. Ana. 6 EPS Ana. |
Jun 2028 6 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
437.51M
est: 423.19M (+3.4%)
|
480.75M
est: 483.28M (-0.5%)
|
565.48M
est: 569.88M (-0.8%)
|
594.40M
est: 604.40M (-1.7%)
|
646.86M
est: 644.69M (+0.3%)
|
666.15M
est: 698.35M (-4.6%)
|
685.87M
est: 731.25M (-6.2%)
|
717.90M
est: 770.42M (-6.8%)
|
771.48M
est: 785.37M (-1.8%)
|
1.01B
est: 1.03B (-1.1%)
|
1.15B
est: 1.17B (-1.2%)
|
1.39B
1.33B – 1.52B
+19.3% YoY
|
1.51B
1.45B – 1.62B
+8.4% YoY
|
1.61B
1.61B – 1.61B
+6.4% YoY
|
| EBITDA |
97.55M
est: 61.04M (+59.8%)
|
93.79M
est: 81.69M (+14.8%)
|
124.58M
est: 81.92M (+52.1%)
|
116.42M
est: 89.82M (+29.6%)
|
107.54M
est: 77.54M (+38.7%)
|
125.45M
est: 65.82M (+90.6%)
|
82.65M
est: 7.24M (+1,040.8%)
|
55.86M
est: 7.57M (+638.3%)
|
96.81M
est: 7.76M (+1,147.0%)
|
191.45M
est: 7.96M (+2,304.6%)
|
240.44M
est: 172.65M (+39.3%)
|
200.77M
191.20M – 218.84M
+16.3% YoY
|
217.67M
208.90M – 233.44M
+8.4% YoY
|
231.68M
231.54M – 231.82M
+6.4% YoY
|
| EBIT |
93.18M
est: 15.24M (+511.2%)
|
71.94M
est: 107.57M (-33.1%)
|
94.73M
est: 85.22M (+11.2%)
|
86.00M
est: 99.75M (-13.8%)
|
83.03M
est: 91.90M (-9.7%)
|
81.39M
est: 88.48M (-8.0%)
|
103.15M
est: 83.60M (+23.4%)
|
14.86M
est: 87.30M (-83.0%)
|
32.96M
est: 89.59M (-63.2%)
|
63.37M
est: 91.87M (-31.0%)
|
190.63M
est: 43.12M (+342.1%)
|
50.14M
47.75M – 54.66M
+16.3% YoY
|
54.37M
52.18M – 58.30M
+8.4% YoY
|
57.86M
57.83M – 57.90M
+6.4% YoY
|
| Net Income |
57.51M
est: 55.11M (+4.4%)
|
46.07M
est: 64.37M (-28.4%)
|
61.10M
est: 55.13M (+10.8%)
|
53.87M
est: 64.34M (-16.3%)
|
50.90M
est: 57.56M (-11.6%)
|
-716.0K
est: 54.24M (-101.3%)
|
19.95M
est: 3.87M (+416.0%)
|
-38.80M
est: 4.04M (-1,061.0%)
|
-28.45M
est: -28.45M (+0.0%)
|
-21.42M
est: -21.42M (+0.0%)
|
48.95M
est: 48.95M (+0.0%)
|
54.61M
51.62M – 57.60M
+11.6% YoY
|
73.08M
67.84M – 80.50M
+33.8% YoY
|
88.30M
80.52M – 102.87M
+20.8% YoY
|
| SGA |
246.95M
est: 97.73M (+152.7%)
|
34.28M
est: 380.48M (-91.0%)
|
42.64M
est: 444.05M (-90.4%)
|
45.65M
est: 464.27M (-90.2%)
|
53.57M
est: 510.78M (-89.5%)
|
55.22M
est: 574.73M (-90.4%)
|
51.13M
est: 610.82M (-91.6%)
|
41.28M
est: 637.85M (-93.5%)
|
72.59M
est: 654.54M (-88.9%)
|
80.47M
est: 671.27M (-88.0%)
|
978.97M
est: 276.45M (+254.1%)
|
321.46M
306.14M – 350.39M
+16.3% YoY
|
348.53M
334.49M – 373.78M
+8.4% YoY
|
370.95M
370.73M – 371.17M
+6.4% YoY
|
| EPS |
0.21
est: 0.18 (+15.8%)
|
0.15
est: 0.17 (-13.6%)
|
0.20
est: 0.20 (-1.7%)
|
0.18
est: 0.18 (-2.7%)
|
0.17
est: 0.16 (+9.1%)
|
0.00
est: 0.09 (-102.8%)
|
0.07
est: 0.05 (+21.4%)
|
-0.13
est: 0.05 (-342.5%)
|
-0.09
est: 0.06 (-247.5%)
|
-0.07
est: 0.12 (-159.6%)
|
0.16
est: 0.17 (-6.0%)
|
0.18
0.17 – 0.19
+6.3% YoY
|
0.25
0.22 – 0.26
+35.5% YoY
|
0.30
0.27 – 0.34
+21.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VanEck - Small Companies Masters ETF MVS.AX | 1.62% | 2.00M | 0.49% |
| 2 | iShares S&P/ASX Small Ordinaries ETF ISO.AX | 0.41% | 362.9K | 0.55% |
| 3 | iShares Edge MSCI Australia Multifactor ETF AUMF.AX | 0.23% | 224.2K | 0.30% |
| 4 | Vanguard MSCI Australian Small Companies Index ETF VSO.AX | 0.23% | 1.81M | 0.30% |
| 5 | Lazard International Dynamic Equity ETF IDEQ | 0.20% | 2.57M | 0.40% |
| 6 | iShares International Developed Small Cap Value Factor ETF ISVL | 0.11% | 359.8K | 0.31% |
| 7 | WisdomTree International SmallCap Dividend Fund DLS | 0.09% | 940.5K | 0.58% |
| 8 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.08% | 364.4K | 0.48% |
| 9 | iShares Ageing Population UCITS ETF AGED.L | 0.07% | 594.5K | 0.40% |
| 10 | iShares International Small-Cap Equity Factor ETF ISCF | 0.06% | 412.0K | 0.24% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Linda Jane Mellors GAICD Cert | Chief Executive Officer, MD & Director | 1M | — |
| Rick Rostolis | Chief Financial Officer | 835.0K | male |
| Imtiaz Bhayat | Chief Information Officer | — | male |
| Jenn Armor | Chief Operating Officer | — | female |
| Jodie Haydon | Chief People Officer | — | female |
| Malcolm Peter Ross AGIA | General Counsel & Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for REG.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
